Status:
RECRUITING
iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
Lead Sponsor:
Mayo Clinic
Conditions:
Prostate Carcinoma
Eligibility:
All Genders
Up to 80 years
Brief Summary
This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic.
Detailed Description
PRIMARY OBJECTIVES: I. Plan and develop a PPCD iCCaRE ViRA model that will provide social determinants of health (SDOH) navigation services, psycho-oncology support and emotional support using qualit...
Eligibility Criteria
Inclusion
- AIM 1: iCCaRE Consortium consumer advocates
- Clinicians who are part of the Translational Research \& Clinical Intervention Services (TRaCIS)
- AIM 2 ALPHA TESTING: iCCaRE consumer advocates \[2 Community Advisory Board (CAB) and 1 non-CAB\]
- AIM 2 BETA TESTING-PATIENTS:
- An African American/Black male
- A patient who has been diagnosed with prostate cancer in Florida at any time in their life, and/or within the previous 6 months has had an abnormal Prostate-Specific Antigen (PSA) lab value and/or Digital Rectal Examination (DRE)
- Minimum age of 30 years old
- Consent to participating in the intervention
Exclusion
- AIM 2 BETA TESTING-PATIENTS:
- Patients who are not African American/Black males
- Patients not diagnosed with prostate cancer in Florida at any time in their life, or within the previous 6 months has not had a normal PSA lab value and/or DRE
- Older than 80 years old
- Are not willing to consent
Key Trial Info
Start Date :
November 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT06535802
Start Date
November 20 2023
End Date
December 1 2026
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980